依托自贸港政策推动中国药械走向全球

Group 1 - The eighth Hainan International Health Industry Expo and the China International Biopharmaceutical Conference focused on cross-border pharmaceutical and medical device cooperation, highlighting the role of Hainan's free trade port policy in promoting Chinese pharmaceuticals globally [2] - The forum addressed the challenges patients face in finding and purchasing medications, with companies like Yididi providing one-stop pharmaceutical services and a rapid response system to meet domestic patients' needs within 72 hours [2][3] - Medikabazaar (China) focuses on serving emerging markets in China and Southeast Asia by offering high-quality, compliant generic drugs and streamlining the supply chain from overseas procurement to domestic customs clearance [2][3] Group 2 - The medical device industry in India is experiencing rapid growth, with significant demand for high-quality, cost-effective medical devices from China, presenting notable overseas market opportunities [3] - Companies face challenges in the medical device export process, including registration, team building, promotion, and after-sales maintenance, necessitating localized operations and a strong execution team [3] - Under the Hainan free trade port policy, Yididi is expanding its global operations, having already initiated localized operations in Southeast Asia and Japan, and is exploring pathways for traditional Chinese medicine to enter the Thai market [3]